Saša Radenković

463 total citations
33 papers, 344 citations indexed

About

Saša Radenković is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Saša Radenković has authored 33 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Saša Radenković's work include Diabetes Management and Research (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Diabetes Treatment and Management (6 papers). Saša Radenković is often cited by papers focused on Diabetes Management and Research (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Diabetes Treatment and Management (6 papers). Saša Radenković collaborates with scholars based in Serbia, Indonesia and Romania. Saša Radenković's co-authors include Gordana Kocić, Tatjana Jevtović−Stoimenov, Dragan Mikić, Radivoj Kocić, Dušica Pavlović, Predrag Djordjević, Slobodan Antić, Marina Stojanović, Milica Pešić and Boris Djindjić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hypertension and Diabetes Obesity and Metabolism.

In The Last Decade

Saša Radenković

30 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saša Radenković Serbia 9 144 107 64 63 45 33 344
MM Suchitra India 11 127 0.9× 71 0.7× 85 1.3× 56 0.9× 31 0.7× 47 408
Shohei Matsuno Japan 11 123 0.9× 88 0.8× 80 1.3× 49 0.8× 105 2.3× 24 484
Fernando Grover‐Páez Mexico 9 88 0.6× 94 0.9× 35 0.5× 42 0.7× 40 0.9× 26 386
Mary F. Carroll United States 7 196 1.4× 81 0.8× 77 1.2× 60 1.0× 97 2.2× 8 458
Silvia Mennuni Italy 5 63 0.4× 117 1.1× 52 0.8× 83 1.3× 37 0.8× 7 406
Yoshitada Yajima Japan 12 239 1.7× 97 0.9× 74 1.2× 90 1.4× 54 1.2× 28 504
Adriana Marton United States 7 124 0.9× 73 0.7× 124 1.9× 54 0.9× 71 1.6× 12 426
Jorge Andrade‐Sierra Mexico 9 67 0.5× 83 0.8× 41 0.6× 112 1.8× 35 0.8× 31 351
Leonardo Pazarín–Villaseñor Mexico 8 61 0.4× 78 0.7× 60 0.9× 133 2.1× 28 0.6× 20 335
Gordana Lazarević Serbia 8 75 0.5× 49 0.5× 73 1.1× 41 0.7× 25 0.6× 25 288

Countries citing papers authored by Saša Radenković

Since Specialization
Citations

This map shows the geographic impact of Saša Radenković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saša Radenković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saša Radenković more than expected).

Fields of papers citing papers by Saša Radenković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saša Radenković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saša Radenković. The network helps show where Saša Radenković may publish in the future.

Co-authorship network of co-authors of Saša Radenković

This figure shows the co-authorship network connecting the top 25 collaborators of Saša Radenković. A scholar is included among the top collaborators of Saša Radenković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saša Radenković. Saša Radenković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rašić-Marković, Aleksandra, Jelica Bjekić-Macut, Dragan Hrnčić, et al.. (2024). Neuroactive steroids in the neuroendocrine control of food intake, metabolism, and reproduction. Endocrine. 85(3). 1050–1057. 4 indexed citations
4.
Radenković, Saša, et al.. (2020). Treatment satisfaction in patients with diabetes mellitus type 1 treated with intensified insulin therapy with insulin analogues. AFMN Biomedicine. 38(3). 240–246. 1 indexed citations
5.
Gluvić, Zoran, Emina Sudar-Milovanović, Milan Obradović, et al.. (2019). Serum nitric oxide levels correlate with quality of life questionnaires scores of hypothyroid females. Medical Hypotheses. 131. 109299–109299. 3 indexed citations
6.
Šavikin, Katarina, Saša Radenković, Marjan Arvandi, et al.. (2019). Chokeberry juice supplementation in type 2 diabetic patients - impact on health status. Journal of Applied Biomedicine. 17(4). 218–224. 21 indexed citations
7.
Pešić, Milica, Milan Radojković, Tatjana Jevtović−Stoimenov, et al.. (2018). Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia. Endocrine. 62(3). 681–691. 4 indexed citations
8.
Pešić, Milica, et al.. (2018). Localised Langerhans cell histiocytosis of the hypothalamic-pituitary region: case report and literature review. HORMONES. 17(1). 119–125. 10 indexed citations
9.
Radenković, Saša, et al.. (2018). THE CORRELATION BETW EEN BODY MASS INDEX AND THYROID STIMULATING HORMONE IN EUTHYROID PERSONS. Acta Medica Medianae. 57(1). 33–37. 1 indexed citations
10.
Radenković, Saša, et al.. (2016). Treatment of Patients with Risk Factors: Compliance and Adherence. SHILAP Revista de lepidopterología. 34(1). 5–11. 1 indexed citations
11.
Kocić, Gordana, Saša Radenković, Radmila Pavlović, et al.. (2014). Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. Renal Failure. 36(4). 613–618. 55 indexed citations
12.
Radenković, Saša, et al.. (2014). ESSENTIAL ARTERIAL HYPERTENSION AND RISK FACTORS ASSOCIATED WITH HYPERTENSIVE NEPHROPATHY. SHILAP Revista de lepidopterología. 15–21. 2 indexed citations
13.
Radenković, Saša, et al.. (2012). Insulin resistance and C reactive protein level. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
14.
Mikić, Dragan, et al.. (2009). Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes. Journal of Endocrinological Investigation. 32(1). 23–27. 24 indexed citations
15.
Stoiljković, Milan, et al.. (2007). Aquaporins role in water balance disorders. Acta Medica Medianae. 46(4). 66–73.
16.
Pešić, Milica, et al.. (2007). Cardiovascular risk factors in patients with subclinical hypothyroidism. Vojnosanitetski pregled. 64(11). 749–752. 7 indexed citations
17.
Radenković, Saša, et al.. (2006). Fine-needle aspiration biopsy of thyroid nodules. 11(1). 14837–14837. 1 indexed citations
18.
Radenković, Saša, et al.. (2006). Comparison between NPH insulin and insulin glargine in intensive insulin therapy in type 1 diabetes mellitus. 11. 1 indexed citations
19.
Siems, Werner, et al.. (2005). Oxidative Stress in Renal Anemia of Hemodialysis Patients Is Mitigated by Epoetin Treatment. Kidney & Blood Pressure Research. 28(5-6). 295–301. 30 indexed citations
20.
Pavlović, Dušica, Radivoj Kocić, Gordana Kocić, et al.. (2000). Effect of four‐week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obesity and Metabolism. 2(4). 251–256. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026